Xiaochen Guo

462 total citations
23 papers, 371 citations indexed

About

Xiaochen Guo is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Xiaochen Guo has authored 23 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Epidemiology and 7 papers in Genetics. Recurrent topics in Xiaochen Guo's work include Fibroblast Growth Factor Research (9 papers), Virology and Viral Diseases (6 papers) and Kruppel-like factors research (6 papers). Xiaochen Guo is often cited by papers focused on Fibroblast Growth Factor Research (9 papers), Virology and Viral Diseases (6 papers) and Kruppel-like factors research (6 papers). Xiaochen Guo collaborates with scholars based in China, Iraq and United States. Xiaochen Guo's co-authors include Deshan Li, Guiping Ren, Junyan Li, Liying Song, Shuai Li, Siming Li, Jinjiao He, Yunye Liu, Dehua Zou and Fuliang Bai and has published in prestigious journals such as International Journal of Pharmaceutics, Biomedicine & Pharmacotherapy and Veterinary Microbiology.

In The Last Decade

Xiaochen Guo

22 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaochen Guo China 10 235 78 66 46 33 23 371
Xiaofei Zhang China 12 260 1.1× 56 0.7× 87 1.3× 52 1.1× 49 1.5× 25 500
Nina V. Fuchs Germany 10 540 2.3× 71 0.9× 93 1.4× 58 1.3× 9 0.3× 18 703
Ji‐Han Xia China 11 179 0.8× 70 0.9× 34 0.5× 66 1.4× 8 0.2× 20 365
Weihua Tian China 14 216 0.9× 22 0.3× 45 0.7× 82 1.8× 26 0.8× 28 436
Yun Deng China 15 209 0.9× 103 1.3× 148 2.2× 65 1.4× 21 0.6× 50 606
Gowri Kalugotla United States 7 148 0.6× 187 2.4× 208 3.2× 38 0.8× 11 0.3× 8 436
Yunye Liu China 13 391 1.7× 240 3.1× 67 1.0× 96 2.1× 21 0.6× 28 707

Countries citing papers authored by Xiaochen Guo

Since Specialization
Citations

This map shows the geographic impact of Xiaochen Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochen Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochen Guo more than expected).

Fields of papers citing papers by Xiaochen Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaochen Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochen Guo. The network helps show where Xiaochen Guo may publish in the future.

Co-authorship network of co-authors of Xiaochen Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaochen Guo. A scholar is included among the top collaborators of Xiaochen Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaochen Guo. Xiaochen Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Yuhan, Xiaochen Guo, Wenying Sun, et al.. (2024). Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sprouting. International Immunopharmacology. 136. 112305–112305. 6 indexed citations
2.
Guo, Xiaochen, Wenying Sun, Xiangxiang Wang, et al.. (2023). Development and Evaluation of the Biological Adjuvant Bivalent Vaccine for Preventing Newcastle Disease and Infectious Bursal Disease. Transboundary and Emerging Diseases. 2023. 1–16. 1 indexed citations
3.
Wei, Lan, Xin Du, Wenying Sun, et al.. (2023). Development and evaluation of Newcastle disease - avian influenza bivalent vector vaccines in commercial chickens. International Immunopharmacology. 120. 110363–110363. 8 indexed citations
4.
Wang, Xiangxiang, Shuang Li, Wenying Sun, et al.. (2023). Evaluation of prevention and treatment effects of fibroblast growth factor-21 in BLM-induced pulmonary fibrosis. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(11). 3299–3313. 3 indexed citations
5.
Guo, Xiaochen, Wenying Sun, Lan Wei, et al.. (2021). Development and evaluation of a recombinant VP2 neutralizing epitope antigen vaccine candidate for infectious bursal disease virus. Transboundary and Emerging Diseases. 68(6). 3658–3675. 8 indexed citations
6.
Guo, Xiaochen, Xiangxiang Wang, Qingyan Yuan, et al.. (2019). Evaluation of a cell model expressing βKlotho for screening FGF21 analogues. Cytotechnology. 71(5). 1033–1041. 1 indexed citations
7.
Wang, Nan, Shuai Li, Xiaochen Guo, et al.. (2018). Fibroblast growth factor 21 improves glucose homeostasis partially via down-regulation of Na+-d-glucose cotransporter SGLT1 in the small intestine. Biomedicine & Pharmacotherapy. 109. 1070–1077. 11 indexed citations
8.
Liu, Zhihang, Liying Song, Yunxin Wang, et al.. (2018). A novel fusion protein attenuates collagen–induced arthritis by targeting interleukin 17A and tumor necrosis factor α. International Journal of Pharmaceutics. 547(1-2). 72–82. 14 indexed citations
9.
Guo, Xiaochen, Qi Zheng, Chao Wu, et al.. (2018). The composite biological adjuvants enhance immune response of porcine circovirus type2 vaccine. Veterinary Microbiology. 228. 69–76. 9 indexed citations
10.
Wang, Nan, Xu Zhang, Junyan Li, et al.. (2018). Improving hyperglycemic effect of FGF-21 is associated with alleviating inflammatory state in diabetes. International Immunopharmacology. 56. 301–309. 21 indexed citations
11.
Li, Shuai, Nan Wang, Xiaochen Guo, et al.. (2018). Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption. Biomedicine & Pharmacotherapy. 108. 355–366. 22 indexed citations
12.
Wang, Nan, Junyan Li, Shuai Li, et al.. (2018). Fibroblast growth factor 21 regulates foam cells formation and inflammatory response in Ox-LDL-induced THP-1 macrophages. Biomedicine & Pharmacotherapy. 108. 1825–1834. 40 indexed citations
13.
Li, Shuai, Xiaochen Guo, Teng Zhang, et al.. (2017). Fibroblast growth factor 21 ameliorates high glucose-induced fibrogenesis in mesangial cells through inhibiting STAT5 signaling pathway. Biomedicine & Pharmacotherapy. 93. 695–704. 22 indexed citations
14.
Yu, Dan, Xianlong Ye, Qiang Wu, et al.. (2017). FGF21 exerts comparable pharmacological efficacy with Adalimumab in ameliorating collagen-induced rheumatoid arthritis by regulating systematic inflammatory response. Biomedicine & Pharmacotherapy. 89. 751–760. 16 indexed citations
15.
Wang, Yunxin, Qiang Wu, Zhihang Liu, et al.. (2017). A recombinant IgG-like bispecific antibody acting as interleukin-1β and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritis. Biomedicine & Pharmacotherapy. 89. 426–437. 13 indexed citations
16.
Yu, Yin-Hang, Jinjiao He, Siming Li, et al.. (2016). Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-κB signaling pathway. International Immunopharmacology. 38. 144–152. 135 indexed citations
17.
Chen, Yanmin, Yin Bai, Xiaochen Guo, et al.. (2016). Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library. Biologicals. 44(4). 271–275. 2 indexed citations
18.
An, Ying, Jinjiao He, Rui Chen, et al.. (2016). Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model. Journal of Biomedical Science. 23(1). 55–55. 18 indexed citations
19.
Guo, Xiaochen, Yunxin Wang, Yang Liu, et al.. (2016). Screening scFv antibodies against infectious bursal disease virus by co-expression of antigen and antibody in the bacteria display system. Veterinary Immunology and Immunopathology. 180. 45–52. 8 indexed citations
20.
Bai, Yin, Yanmin Chen, Nan Zhang, et al.. (2015). Isolation of the neutralization ScFvs against HBV infection from the immunized population. Current Pharmaceutical Biotechnology. 16(10). 902–910. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaofei Zhang Breakdown of academic impact, for papers by Nina V. Fuchs Breakdown of academic impact, for papers by Ji‐Han Xia Breakdown of academic impact, for papers by Weihua Tian Breakdown of academic impact, for papers by Yun Deng Breakdown of academic impact, for papers by Gowri Kalugotla Breakdown of academic impact, for papers by Yunye Liu
Rankless by CCL
2026